cyanoginosin LR

cyclic heptapeptide from cyanobacterium Microcystis aeruginosa

Also Known As:

microcystin LR; MCYST-LR; cyanoginosin-lr; cyclo(2,3- didehydro- n- methylalanyl- D- alanyl- l- leucyl- erythro- 3- methyl- D- beta- aspartyl- l- arginyl- (2S,3S,4E,6E,8S,9S)- 4,5,6,7- tetradehydro- 9- methoxy- 2,6,8- trimethyl- 10- phenyl- 3- aminodecanoyl- d- gamma- glutamyl); cyclo(Ala- Leu- MAsp- Arg- Adda- isoGlu- Mdha); cyclo(alanyl- leucyl- beta- methylaspartyl- arginyl- (3- amino- 9- methoxy- 2,6,8- trimethyl- 10- phenyldeca- 4,6- dienoic acid)- isoglutamyl- N- methyldehydroalanyl); microcystin-LR; microcystin-YR; microcystin-la, 5-l-arginine-; microcystin-leucine arginine; microcystin-leucine arginine (MC-LR); toxin I (Microcystis aeruginosa); toxin I, cyanobacterium; toxin t-17 (Microcystis aeruginosa)

Pharmalogical Action Categories:

D004791 - Enzyme Inhibitors

Biological Factors: 2472
- Biological Toxins: 20
  - Bacterial Toxins: 814
    - Cyanobacteria Toxins: 107
      - Microcystins: 154
        cyanoginosin LR: 200
  - Marine Toxins: 124
    - cyanoginosin LR: 200
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Microcystins: 154
      - cyanoginosin LR: 200
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Microcystins: 154
      - cyanoginosin LR: 200

Yuki Hotta Selected Research

Yuki Hotta Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure